Final Scientific Programme
Instructions for Speakers
|
|
| 9:00–9:15 | Official opening |
| Chair: Gottfried Fischer, Antonij Slavcev | |
| 9:15–9:45 | Opening lecture |
| Chair: Gottfried Fischer, Elissaveta Naumova | |
| Marcelo Fernandez-Viña: Global diversity of HLA examined, extended coverage by NGS | |
| 9:45–11:15 | Organ transplantation, epitope matching, antibody-mediated rejection |
| Chair: Sebastian Heidt, Caner Suesal | |
| Sebastian Heidt: Towards epitope matching in kidney allocation | |
| Caner Suesal: CTS data on the impact of underimmunosuppression on kidney graft survival | |
| Ondrej Viklicky: HLA incompatible kidney transplantation - a single center experience | |
| Georg Böhmig: What we have learned from the Borteject trial | |
| Janka Slatinska: Do C1q-positive donor specific antibodies have prognostic effect in patients with resistant antibody-mediated rejection treated with bortezomib? | |
| 11:15–11:30 | Coffee Break |
| 11:30–12:30 | Immunogenetics, anthropology, disease associations |
| Chair: Martin Petrek, Zorana Grubic, Blanka Vidan-Jeras | |
| Elissaveta Naumova: Immunogenetics of aging - new prospectives in the NGS era | |
| Zorana Grubić: HLA allele and haplotype diversity in the Croatian population: State of the art | |
| Blanka Vidan-Jeras: When Type 1 Diabetes meets Celiac Disease | |
| Milena Vrana: Analysis of HLA-DQB1* locus in Czech patient with central Hypersomnias | |
| 12:30–13:30 | Symposium OneLambda/Biomedica |
| 13:30–14:15 | Lunch |
| 14:15–16:00 | Abstract Session – Organ Transplantation, various |
| Chair: Renata Zunec, Monica Dutescu | |
| Renata Zunec: Solid organ transplantation in Croatia: 10-years experience with EUROTRANSPLANT | |
| Moshe Israeli: Long term results of desensitization protocol with and without rituximab in highly sensitized kidney transplant recipients |
|
| Orjeta Bonaca: Detection and identification of anti-HLA antibodies in patients on waiting list for kidney transplantation |
|
| Sedat Karadeniz: Augmented Virtual-Cross-Match for Donor-Induced Antibody Prediction by using high resolution HLA typing and HLA epitope mapping for better donor match | |
| Barbora Kovandova: Antibody-mediated rejection after liver transplantation - selected immunological parameters | |
| Antonij Slavcev: Epitope matching in kidney transplantation – a single center study | |
| Sabine Wenda: Prediction of the outcome of Flow Crossmatches by antibodies detection via the bead array technique | |
| Marta Dratwa: MICA expression is associated with MICA-129Met/Val polymorphism and changes during therapy with TNF inhibitors in patients with Rheumatoid Arthritis | |
| Joanna Wielinska: The rs1800795 CC homozygosity might have an unfavourable effect in patients with rheumatoid arthritis | |
| 16:00–16:30 | Coffee Break |
| 16:30–17:30 | External proficiency testing |
| Chair: Katarzyna Bogunia-Kubik, Ingrid Faé, Gottfried Fischer | |
| Gottfried Fischer: The CET-EPT Exercise 2017 | |
| Katarzyna Bogunia-Kubik: HLA Proficiency Testing for Central and East Europe 2017 - activity report | |
| E. Ratajová & M. Vraná: EPT offered by the HLA Department of the Institute of Hematology and Blood Transfusion in Prague, Czech Republic: Detection of HLA alleles associated with diseases | |
| Kristyna Pegova: Results of EPT for cell chimerism analysis in 2017 | |
| Ilias Doxiadis: Proficiency testing in the 21st century | |
| 19:00–23:00 | Conference Dinner |
Friday, March 9, 2018 |
|
| 8:45–10:00 | Stem cell registries, chimerism |
| Chair: Marco Andreani, Frantisek Mrazek, Milena Vraná | |
| Marco Andreani: The study of engraftment after hematopoietic stem cell transplantation: from the presence of mixed chimerism to the development of immunological tolerance | |
| Nezih Cereb: Histogenetics’s experience with Third Generation sequencing | |
| Monica Dutescu: Donor Selection and Allo-HSCT Within The National Transplant Program in Romania – Current Achievements and Future Tasks |
|
| Frantisek Mrazek: Searching for nonHLA/nonKIR gene variants associated with allogeneic HSCT outcome – selected functional and biological aspect | |
| Kristyna Pegova: Chimerism as an important marker in post-transplant monitoring | |
| 10:00–10:15 | Coffee Break |
| 10:15–12:00 | Abstract Session - Stem Cell Transplantation, various |
| Chair: Elissaveta Naumova, Frantisek Mrázek | |
| M. Vraná & V. Šiffnerová: Hematopoietic Stem Cell Donor Selection – an impact of HLA test accuracy to the patient post transplant survival | |
| Marija Maskalan: Contribution of frequent HLA-A~B~DRB1 haplotypes to donor search outcome in Croatia | |
| Marija Burek Kamenaric: Detection of new, very rare and rare HLA alleles among volunteer hematopoietic stem cell donors from Croatia | |
| Marie Kurikova: Czech Stem Cells Registry – changes in HLA typing and donor recruitment | |
| Jacek Nowak: Role of donor HLA mismatch, KIR-ligand mismatch and NK cell licensing in leukemia relapse after hematopoietic stem cell transplantation | |
| Moshe Israeli: Current trends in searching for matched unrelated donors in Israel: a current update (2013-2017) | |
| Ekaterina Khamaganova: HLA-DPB1 mismatches in related and unrelated 10/10 matched allogeneic hematopoietic stem cell transplantation | |
| Ingrid Faé: Detection of allele specific clinically significant single nucleotide polymorphisms in the 3’UTR of DPB1 genes with Next Generation Sequencing (NGS) | |
| 12:00–13:00 | Symposium BAG Health Care GmbH and "APR" spol. s r. o. / Immucor Inc. |
| Lunch will be served in the hall during the symposium. | |
| 13:00–13:15 | Break |
| 13:15–14:30 | EFI Accreditation - Current issues |
| Chair: Gottfried Fischer, Blanka Vidan-Jeras, Ingrid Faé | |
| Ingrid Faé, Blanka Vidan-Jeras: News in region 5a and 5b | |
| Blanka-Vidan-Jeras: ISO and EFI combined inspections in region 5 and elsewhere in Europe | |
| Ingrid Faé: The accreditation web tool | |
| 14:30–15:00 | Round table discussion |
| 15:00 | Closure |